Perioperative treatment with cilostazol reverses steatosis and improves liver regeneration after major hepatectomy in a steatotic rat model

Authors: Sebastian Holländer, Maximilian von Heesen, Gereon Gäbelein, Julie Mercier, Matthias W. Laschke, Michael D. Menger, Matthias Glanemann, Antonios E. Spiliotis

Source: Scientific Reports, Vol 15, Iss 1, Pp 1-13 (2025)

Subject Terms: Obesity, Non-alcoholic fatty liver disease, Hepatectomy, Cilostazol, Liver regeneration, Medicine, Science

File Description: electronic resource

Relation: https://doaj.org/toc/2045-2322

Access URL: https://doaj.org/article/6facd203b5a24b52bf51325aa9968efc

Protective effects of cilostazol via the HNF1α/FXR signalling pathway and anti-apoptotic mechanisms in a rat model of estrogen-induced intrahepatic cholestasis

Authors: Marwa Hassan, Maha B. Salem, Olfat A. Hammam, Mohamed ElZallat

Source: Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)

Subject Terms: Intrahepatic cholestasis, Cilostazol, HNF1α/FXR pathway, CYP7A1, Apoptosis, Medicine, Science

File Description: electronic resource

Relation: https://doaj.org/toc/2045-2322

Access URL: https://doaj.org/article/1b224932697a4513928555d72c6dd0f5

New options for cilostazol-based dual antiplatelet therapy for ischaemic stroke prevention in East Asian populations: a systematic review and meta-analysis

Authors: Xiaorui Wang, Yixin Wang, Qiang Zheng, Pengwei Li, Jingli Yin, Miaomiao Wang, Liangyu Zou, Jie Wang, Jialin Pan, Lei Qin, Song Luo, Lijuan Yang

Source: Frontiers in Pharmacology, Vol 16 (2025)

Subject Terms: ischaemic stroke, cilostazol, dual antiplatelet therapy, meta-analysis, systematic review, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2025.1533674/full; https://doaj.org/toc/1663-9812

Access URL: https://doaj.org/article/14bf1f3ed5c7438fa4895dc45414db5f

Cilostazol is a promising anti-pseudomonal virulence drug by disruption of quorum sensing

Authors: Mohammed W. Al-Rabia, Hani Z. Asfour, Nabil A. Alhakamy, Mohammed A. Bazuhair, Tarek S. Ibrahim, Hisham A. Abbas, Basem Mansour, Wael A. H. Hegazy, Noura M. Seleem

Source: AMB Express, Vol 14, Iss 1, Pp 1-14 (2024)

Subject Terms: Pseudomonas aeruginosa, Cilostazol, Quorum sensing, Anti-virulence, Healthcare, Antimicrobial resistance, Biotechnology, TP248.13-248.65, Microbiology, QR1-502

File Description: electronic resource

Relation: https://doaj.org/toc/2191-0855

Access URL: https://doaj.org/article/d74c22041de24b48956236d01a2c28c0

Cilostazol niosomes-loaded transdermal gels: An in vitro and in vivo anti-aggregant and skin permeation activity investigations towards preparing an efficient nanoscale formulation

Authors: Mahmoud Reda A., Abdelhafez Wael A., Mahmoud Essam A., Hassan Yassar, Amin Mohammed A., Zayed Gamal M., Mohammed Hamdoon A., El-Rasoul Saleh A., Maswadeh Hamzah, Abomughaid Mosleh M., Khan Riaz A.

Source: Nanotechnology Reviews, Vol 13, Iss 1, Pp 320-58 (2024)

Subject Terms: cilostazol, niosomes, nanotechnology, nanomedicine, drug delivery, transdermal drug delivery, ether injection, coagulation-time measurement, Technology, Chemical technology, TP1-1185, Physical and theoretical chemistry, QD450-801

File Description: electronic resource

Relation: https://doaj.org/toc/2191-9097

Access URL: https://doaj.org/article/800b44a423be45a8aa4a1639de3bddd8

Cilostazol protective effect on nedaplatin-induced genotoxicity in cultured human lymphocytes

Authors: Karem H. Alzoubi, Abeer M. Rababa’h, Omar F. Khabour, Fian Nuseir

Source: Toxicology Reports, Vol 14, Iss , Pp 101928- (2025)

Subject Terms: Nedaplatin, Cilostazol, Mitotic index, Human cultured lymphocytes, Sister chromatid exchanges, Genotoxicity, Toxicology. Poisons, RA1190-1270

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2214750025000460; https://doaj.org/toc/2214-7500

Access URL: https://doaj.org/article/01a5e48399df40c9af6da2332bb0e481

Cilostazol after endovascular therapy for femoropopliteal peripheral arterial disease: A systematic review and meta-analysis

Authors: Cerecedo, Christian D. ^{a, ∗}, Silva, Aaron ^a, Alia, Valentine S. ^a, Vargas, Ana ^a, Garza, Alejandro ^b, El Shazly, Omar ^c, Candil, Alejandro J. ^a

Source: In Journal of Vascular Surgery March 2025 81(3):767-774

Cilostazol counteracts mitochondrial dysfunction in hepatic encephalopathy rat model: Insights into the role of cAMP/AMPK/SIRT1/ PINK-1/parkin hub and p-CREB /BDNF/ TrkB neuroprotective trajectory

Authors: Gad, Enas S. ^{a, b}, Aldossary, Sara A. ^a, El-Ansary, Mona R. ^c, Abd El-Galil, Mona M. ^d, Abd-El-Hamid, Asmaa Hassan ^d, El-Ansary, Amira R. ^e, Hassan, Noha F. ^{f, ⁎}

Source: In European Journal of Pharmacology 15 January 2025 987

Rationale and design of the efficacy and safety of combination of cilostazol and gingko biloba extract EGb 761 in patients with acute non-cardioembolic ischemic stroke (RENEW): A pilot and feasibility randomized controlled trial

Authors: Ha, Sang Hee ^a, Lee, Young Bae ^a, Kang, Hyun goo ^b, Choi, Kwang-Ho ^c, Kim, Beom Joon ^d, Woo, Ho Geol ^e, Kwon, Hyuk Sung ^f, Song, Tae-Jin ^{g, ⁎, †}, Kim, Bum Joon ^{h, ⁎⁎, †}

Source: In Journal of Stroke and Cerebrovascular Diseases January 2025 34(1)

Cilostazol geno-protective effects mitigate carbamazepine-induced genotoxicity in human cultured blood lymphocytes

Authors: Enaam M. Al Momany, Abeer M. Rababa’h, Karem H. Alzoubi, Omar F. Khabour

Source: Toxicology Reports, Vol 13, Iss , Pp 101814- (2024)

Subject Terms: Carbamazepine, Cilostazol, Sister chromatid exchange, Cell kinetic assays, Genotoxic, Cytotoxic, Toxicology. Poisons, RA1190-1270

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2214750024001975; https://doaj.org/toc/2214-7500

Access URL: https://doaj.org/article/f724eb043cae4a34ad3aae8c7a3c7a5a

Statins boost beneficial pleiotropic cardiovascular effects of cilostazol in angiotensin-II hypertensive rats

Authors: Hamdy, Ahmed ^{a, ⁎}, El-Bassossy, Hany M. ^{a, b}, Elshazly, Shimaa M. ^a, El-Sayed, Shaimaa S. ^a

Source: In European Journal of Pharmacology 5 June 2025 996

Investigation of the effects of cilostazol on the myocardial ischemia-reperfusion injury of rats.

Authors: Anar Amrah

Source: Ķazaķstannyṇ Klinikalyķ Medicinasy, Vol 21, Iss 2, Pp 59-65 (2024)

Subject Terms: cilostazol, Myocard, İschemia reperfusion injury., Internal medicine, RC31-1245, Specialties of internal medicine, RC581-951

File Description: electronic resource

Relation: https://www.clinmedkaz.org/download/investigation-of-the-effects-of-cilostazol-on-the-myocardial-ischemia-reperfusion-injury-of-rats-14494.pdf; https://doaj.org/toc/1812-2892; https://doaj.org/toc/2313-1519

Access URL: https://doaj.org/article/e76a208d27fb41b989de6140cbf9ed61

Development and Characterization of In Situ Gelling Nasal Cilostazol Spanlastics

Authors: Maryana Salamah, Mária Budai-Szűcs, Bence Sipos, Balázs Volk, Gábor Katona, György Tibor Balogh, Ildikó Csóka

Source: Gels, Vol 11, Iss 2, p 82 (2025)

Subject Terms: cilostazol, spanlastics, in situ gel, Phytagel®, Poloxamer-407, chitosan, Science, Chemistry, QD1-999, Inorganic chemistry, QD146-197, General. Including alchemy, QD1-65

File Description: electronic resource

Relation: https://www.mdpi.com/2310-2861/11/2/82; https://doaj.org/toc/2310-2861

Access URL: https://doaj.org/article/3a250c6a3411440784c7df844a5cc1a6

Preliminary Study by Differential Scanning Calorimetric Analysis of Red Blood Cells in Peripheral Artery Disease Patients Treated with Cilostazol: Correlation with Improvements in Walking Distance

Authors: Dénes Lőrinczy, Dorottya Szabó, László Benkő

Source: Pharmaceuticals, Vol 18, Iss 1, p 60 (2025)

Subject Terms: cilostazol, peripheral arterial disease, intermittent claudication, DSC, human red blood cells, Medicine, Pharmacy and materia medica, RS1-441

File Description: electronic resource

Relation: https://www.mdpi.com/1424-8247/18/1/60; https://doaj.org/toc/1424-8247

Access URL: https://doaj.org/article/ed35294cca5143b2ba27623e61ccad09

Cilostazol for the treatment of distal symmetrical polyneuropathy in diabetes mellitus: Where do we stand?

Authors: Pantazopoulos, Dimitrios ^a, Gouveri, Evanthia ^a, Rizzo, Manfredi ^b, Papanas, Nikolaos ^{a, ⁎}

Source: In Journal of Diabetes and Its Complications December 2024 38(12)

Cilostazol protects against degenerative cervical myelopathy injury and cell pyroptosis via TXNIP-NLRP3 pathway

Authors: Fei Xu, Zhuo Tian, Zhengguang Wang

Source: Cell Division, Vol 19, Iss 1, Pp 1-13 (2024)

Subject Terms: Degenerative cervical myelopathy, Cilostazol, Pyroptosis, TXNIP, NLRP3, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Cytology, QH573-671

File Description: electronic resource

Relation: https://doaj.org/toc/1747-1028

Access URL: https://doaj.org/article/0acd98819605425c958ed1f0d881d6d0

Benefits of Cilostazol’s Effect on Vascular and Neuropathic Complications Caused by Diabetes

Authors: Diego Castro Musial, Maria Eduarda Ajita, Guilherme Henrique Souza Bomfim

Source: Medical Sciences, Vol 13, Iss 1, p 1 (2024)

Subject Terms: cilostazol, peripheral arterial disease, diabetic neuropathy, diabetes, claudication, Medicine

File Description: electronic resource

Relation: https://www.mdpi.com/2076-3271/13/1/1; https://doaj.org/toc/2076-3271

Access URL: https://doaj.org/article/c1e29ab5937145e0b89b35357eccacf0

Theoretical Investigations on Free Energy of Binding Cilostazol with Different Cyclodextrins as Complex for Selective PDE3 Inhibition

Authors: Marta Hoelm, Nilkanta Chowdhury, Sima Biswas, Angshuman Bagchi, Magdalena Małecka

Source: Molecules, Vol 29, Iss 16, p 3824 (2024)

Subject Terms: cyclodextrins, cilostazol, cyclodextrin–cilostazol complex, ligand–protein interactions, molecular docking simulations, drug delivery, Organic chemistry, QD241-441

File Description: electronic resource

Relation: https://www.mdpi.com/1420-3049/29/16/3824; https://doaj.org/toc/1420-3049

Access URL: https://doaj.org/article/8a095a73c76543e68a3935ceaa0d1703

2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Authors: Gornik, Heather L., Aronow, Herbert D., Goodney, Philip P., Arya, Shipra, Brewster, Luke Packard ^†, Byrd, Lori ^‡, Chandra, Venita ^§, Drachman, Douglas E., Eaves, Jennifer M., Ehrman, Jonathan K. ^‖, Evans, John N. ^¶, Getchius, Thomas S.D., Gutiérrez, J. Antonio, Hawkins, Beau M., Hess, Connie N., Ho, Karen J., Jones, W. Schuyler ^#, Kim, Esther S.H. ^∗∗, Kinlay, Scott, Kirksey, Lee ^††, Kohlman-Trigoboff, Debra, Long, Chandler A., Pollak, Amy West, Sabri, Saher S., Sadwin, Lawrence B. ^‡, Secemsky, Eric A., Serhal, Maya, Shishehbor, Mehdi H. ^‡‡, Treat-Jacobson, Diane ^§§, Wilkins, Luke R. ^‖‖

Source: In Journal of the American College of Cardiology 18 June 2024 83(24):2497-2604

Pretreatment with Cilostazol Attenuates Carboplatin Induced Cytotoxicity and Genotoxicity in Bronchial Epithelial Cells (Beas-2B) and Human Blood Lymphocytes

Authors: Mohammad Shokrzadeh, Mahboube Rahmati, Elahe Gharehkhani, Rouzbeh Zare, Parsa Pourmohammadi, Shaghayegh Aghajanshakeri

Source: Journal of Mazandaran University of Medical Sciences, Vol 33, Iss 227, Pp 24-36 (2023)

Subject Terms: cilostazol, carboplatin, micronucleus assay, cytotoxicity, Medicine, Medicine (General), R5-920

File Description: electronic resource

Relation: http://jmums.mazums.ac.ir/article-1-19430-en.pdf; https://doaj.org/toc/1735-9260; https://doaj.org/toc/1735-9279

Access URL: https://doaj.org/article/b56d5cad42064d37bfd302ff20abdec9